Skip to main content

Sedentary Lifestyle

1
Pipeline Programs
9
Companies
6
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

7 companies ranked by most advanced pipeline stage

Temple Therapeutics
Temple TherapeuticsNetherlands - Geleen
1 program
1
PA+ Smoking CessationPhase 11 trial
Active Trials
NCT02220465Unknown90Est. Dec 2015
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Activity LikingN/A1 trial
Active Trials
NCT02809521Completed13Est. Sep 2016
Innovation Pharmaceuticals
1 program
Online HIIT InterventionN/A1 trial
Active Trials
NCT05467280Unknown281Est. Feb 2023
UNION therapeutics
UNION therapeuticsDenmark - Hellerup
1 program
Online HIIT InterventionN/A
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
Physical ActivityN/A1 trial
Active Trials
NCT03417440Completed111Est. Jan 2021
Shield Therapeutics
Shield TherapeuticsMA - Wellesley
1 program
Social walking interventionN/A1 trial
Active Trials
NCT01139541Completed224Est. Jan 2011
Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
Total Worker HealthN/A1 trial
Active Trials
NCT03556670Unknown264Est. Dec 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Temple TherapeuticsPA+ Smoking Cessation
Innovation PharmaceuticalsOnline HIIT Intervention
Oregon TherapeuticsTotal Worker Health
Angeles TherapeuticsPhysical Activity
Human BioSciencesActivity Liking
Shield TherapeuticsSocial walking intervention

Clinical Trials (6)

Total enrollment: 983 patients across 6 trials

NCT02220465Temple TherapeuticsPA+ Smoking Cessation

Step-up to Quit: Using Low-to-moderate Intensity Exercise for Reducing Smoking Cue Reactivity Among Low-income Smokers

Start: Apr 2013Est. completion: Dec 201590 patients
Phase 1Unknown
NCT05467280Innovation PharmaceuticalsOnline HIIT Intervention

WISE Project - Women's Involvement in Steady Exercise

Start: Aug 2022Est. completion: Feb 2023281 patients
N/AUnknown
NCT03556670Oregon TherapeuticsTotal Worker Health

Active Workplace Study

Start: Jul 2018Est. completion: Dec 2020264 patients
N/AUnknown
NCT03417440Angeles TherapeuticsPhysical Activity

A Smartphone App to Improve Physical Activity

Start: Apr 2018Est. completion: Jan 2021111 patients
N/ACompleted
NCT02809521Human BioSciencesActivity Liking

Increasing Spontaneous Non-exercise Activity (The Sitting Study)

Start: Jun 2016Est. completion: Sep 201613 patients
N/ACompleted
NCT01139541Shield TherapeuticsSocial walking intervention

Testing Strategies for Increasing Exercise

Start: Jun 2010Est. completion: Jan 2011224 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

9 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.